L-selectin dependent upregulation of CD69 was seen in tumors and lymphoid organs suggesting that a ligand-expressing accessory cell is unlikely to be tumor cells but an antigen-presenting cell that matures in the tumor microenvironment and re-locates to lymphoid organs. The gene discussed is SELL; the disease is neoplasm.